Key words: albumin; CAPD; survival Hypothesis. Trends in serum albumin concentration over time provide a better prediction of clinical outcome in CAPD patients than a single mean value.
at 36 months in 225 adult CAPD patients. Mean serum Introduction albumin was determined for the first (SA1) and second (SA2) 6 months of treatment and patients grouped Serum albumin is a powerful predictor of outcome in according to SA1 (group I, >37; group II, 34-37; patients on dialysis. Data from more than 12 000 US group III, <34 g/l ) and according to the change in haemodialysis patients showed that the odds ratio for serum albumin (DSA) between the first and second 6 death increased progressively as albumin decreased less months (increased/static or decreased). Patient (PS ) than the reference range of 4-4.4 g/dl, with a threefold and technique (TS ) survival were determined by greater risk of dying for an albumin of 3-3.4 g/dl and Kaplan-Meier survival analysis. The effect of SA1 and a 12-fold greater risk once values were less than DSA on survival were determined in a multivariate 2.5 g/dl [1 ] . A study of 680 CAPD patients reported Cox regression analysis model that included age and that for each 1 g/l decrement in serum albumin at the presence or absence of a systemic disease.
start of CAPD, relative risk of death increased by 6% Results. By SA1 group, PS and TS survival at 36 [2] . Gamba et al. [3 ] reported that albumin just prior months were 94 and 76% (group I ), 64 and 53% to commencing CAPD was the most powerful predictor (group II ) and 70 and 52% (group III ). If DSA of death in 190 patients followed for a mean of 12 increased/remained static, then SA1 did not predict PS months. Blake et al. [4 ] found that in 76 patients, (group I, 100%; group II, 96%; group III, 74%; P= serum albumin averaged every 6 months was lower in n.s.) or TS (group I, 72%; group II, 63%; group III, the 6 months prior to an episode of technique failure 65%; P=n.s.). If DSA decreased, PS was worse in or patient death, and albumin averaged over the first groups II and III, both as compared to group I (PS 6 months of CAPD predicted technique failure at a group I, 88%; group II, 52%; group III, 34%; P=0.02) later time, but not mortality. In a further study the and as compared to the groups II and III when DSA initial albumin (at the start of the study, which was increased (PS group II, 74 vs 52%, P=0.05; group III, not the start of CAPD treatment) was significantly 82 vs 34%, P=0.005) The same trend was seen for TS.
lower in non-survivors than survivors amongst 80 In the multivariate Cox regression model, age, direction patients followed for an average of 19 months and was of change in serum albumin, and presence of a multian independent risk factor for mortality [5 ] . However, system disease were significant predictors of survival, a retrospective review of 201 patients [6 ] and a prowhereas SA1 was not.
spective study of 61 patients [7] found that albumin Conclusion. Early hypoalbuminaemia in CAPD only was correlated with patient survival in univariate, but predicts a worse patient and technique survival if mean not multivariate analysis. serum albumin decreases further from the first to If serum albumin is strongly correlated with CAPD second 6 months of dialysis therapy. Change in serum failure, then albumin values could be useful in early albumin between the first and second 6 months of prediction of patients most likely to fail. An albumin CAPD and the mean serum albumin over the first 6 concentration at a single time point may not be of months together offer better discrimination of outcome help in predicting the outcome of an individual patient than either alone.
and we have reviewed serial data obtained over two time periods to determine whether change in mean Correspondence and offprint requests to: Dr C. H. Jones, Department serum albumin would allow better prediction of out- Methods each, systemic lupus erythematosus in three, postpartum haemorrhage and renal tract tuberculosis in two The study comprised a retrospective review of serial each, gout and multiple myeloma in one each, and serum albumin measurements in all adult patients unknown in 51 cases. Seventy-three cases were considenrolled in the CAPD programme of St James's ered to have a 'multisystem' disease. University Hospital, Leeds from 1982 to 1995.
Seventy-nine patients continued on CAPD and 146 Approximately 30% of the total dialysis population ceased therapy (34 transferred to haemodialysis, 82 was managed by CAPD. Peritonitis rate varied, but transplanted, and 30 died). Table 1 shows the number was l episode per 22 patient months in the final year of patients ceasing therapy according to serum albumin of the study. Only patients continuing on peritoneal group and change in serum albumin. Patient and dialysis for at least 12 months were included. Albumin technique survival at 36 months were 76 and 57% was measured by the bromocresol green method respectively. Considering mean albumin measurements (normal range 37-49 g/l ) throughout the study period.
alone, there was no significant difference in mean For each patient, albumin was averaged from all results albumin over the first 6 months (SAl ) according to obtained over the first and second 6 months from the outcome at 36 months ( Figure 1 ). The mean albumin start of CAPD, with SA1 and SA2 being the mean over the second 6 months (SA2) was lower (P<0.0001) albumin for the first and second 6 months respectively.
in patients who subsequently died than in all other For comparison of outcomes, patients were divided groups. SA2 was significantly lower in those continuing into three groups according to SA1 (group I CAPD than in transplanted patients, although the SA1>37 g/l; group II, SA1=34-37 g/l; group III, overlap between groups was considerable ( Figure 1 ). SA1<34 g/l ). Patients were further classified as having According to SAl, groups I (normoalbuminaemia), an increased/stable or a decreased albumin, according II (mild hypoalbuminaemia), and III (moderate to to the change in mean serum albumin between the first severe hypoalbuminaemia) contained 81, 73 and 71 and second 6 months (SA1 SA2). A decrease of patients respectively. Patient (PS ) and technique ( TS) >0.1 g/l led to the patient's being placed in the survival were significantly greater in group I (PS 92%, decreased group. Patient status at 36 months from TS 73%) compared to groups II (PS 64%, TS 52%) commencement of CAPD was determined as continuand III (PS 69%, TS 50%; Table 2 ). There was no ing on CAPD, transferred to haemodialysis (HD), difference between the two lower albumin groups. CAPD ceased due to a functioning transplant (Tx), or
The mean serum albumin over the second 6 months death. If death occurred within 2 months of transfer had increased or remained static in 142 and decreased to HD, or was a direct result of the process leading to in 83 patients compared to the mean serum albumin cessation of CAPD, then the outcome was classified over the first 6 months. In Kaplan-Meier survival as a death. The presence or absence of a systemic analysis, following stratification of groups I, II and III disease (defined as amyloidosis, multiple myeloma, according to the direction of change in serum albumin insulin-dependent diabetes mellitus ( IDDM), systemic from the first to second 6 months, patient and techlupus erythematosus, vasculitis, sarcoidosis, or hypernique survival were not significantly different according tensive renal disease) was recorded. Comparison of to SA1 if albumin increased/remained stable (PS group mean albumin between groups was made by ANOVA, I, 96%; group II, 74%; group III, 82%; P=n.s. and TS with Bonferroni correction for significance, and comgroup I, 72%; group II 63%; group III, 65%; P=n.s.) parison of survival by Kaplan-Meier survival analysis, (Table 3 and Figures 2, 3) . If serum albumin decreased, with log rank test of significance determined for each SAl continued to predict patient and technique survival stratum. The effect on survival of age, mean serum (PS group I, 88%; group II, 52%; group III, 34%; P= albumin over the first 6 months, patient group accord-0.02 and TS group I, 73%; group II, 41%; group III, ing to SA1 ( I, II or III ), direction of change in serum 16%; P=0.002). In the two low albumin groups, PS albumin (increase or decrease), and presence/absence was significantly greater if serum albumin increased as of a multisystem disease was tested in a univariate Cox compared to decreased (group II 74% vs 52%, P=0.05 regression analysis. Significant variables were entered and group III 82% vs 34%, P=0.005). TS showed the in a multivariate Cox model. A P value <0.05 was taken as significant. When age, presence of systemic disease, direction of change in serum albumin, and SA1 were entered into Table 2 . Kaplan-Meier analysis of patient and technique survival at a multivariate analysis, age, systemic disease, and 36 months according to mean serum albumin during the first six months of CAPD (SA1-group I, >37; group II, 34-37; group III, direction of change in serum albumin remained signi-<34 g/l ) and the change in mean serum albumin during the first ficant (Table 4 ) . Serum albumin, measured at the start of CAPD [2, 3] , averaged over 6-month treatment intervals [4] or aver- The mechanism of hypoalbuminaemia in CAPD patients is multifactorial. Most emphasis has been placed on albumin being dependent on nutritional state [9-11 ]. However, the presence of diabetes mellitus [4 ] same trend (group II. 63% vs 41%, P=n.s. and group III: 65% vs 16% P=0.005, Table 3 ).
and other systemic diseases [7] , a high dialysate:plasma creatinine ratio [4] , increasing age [4 ] , and hypervolaeIn a univariate Cox regression analysis, age, the presence of a systemic disease, and the direction of mia [12] have also been associated with lower serum albumin. Albumin is a negative acute-phase protein change in serum albumin between the first and second 6 months of treatment were significant predictors of and, in haemodialysis patients, serum concentrations of positive acute-phase proteins are greater in hypoaloutcome (Table 4 ) . SA1 approached significance. Patient group according to SA1 was not significant. buminaemic patients, suggesting the presence of poorly Table 4 . Cox regression analysis of the effect of age, presence of IDDM or a multisystem disease (see text), mean serum albumin over the first six months of CAPD (SA1), and the change in serum albumin between the first and second six months of CAPD (DSA) on survival in univariate and multivariate analysis. b=regression coefficient, SE=standard error, P=significance The use of single albumin measurements is unsatisfactory, as albumin may decline quickly (and reversibly) during acute illness episodes. The serum albumin at the start of dialysis may be influenced by pre- between the first and second six months. Log rank test of significance. hypoalbuminaemic patients had the greatest risk of failure on CAPD might allow the development of Table 3 . Kaplan-Meier analysis of patient and technique survival at strategies for intervention prior to treatment failure.
36 months according to mean serum albumin over the first 6 months We have explored whether the change in albumin of CAPD (group I,>37; group II, 34-37; group III,<34 g/l ) and over a clinically useful time ( between the first and the change between the mean serum albumin in the first and second second 6 months of dialysis) would be a useful pre-6 months (DSA). Log rank test of significance. Numbers in parendictor of outcome, particularly when considered theses indicate the number of patients in each group together with the mean albumin over the first 6 months. An absolute change of 0.l g/l in a serum albumin 15 had patient and technique survivals of only 34% and 16%. The significance of change in serum albumin was retained in multivariate analysis, whilst that of defined inflammation [13 ] . Hypoalbuminaemia has been strongly correlated with the presence and develop-mean serum albumin during the first 6 months (either as actual values or as grouped bands) was not. ment of cardiac failure and ischaemic heart disease [14 ] . Most of these variables are also predictive of
The observed trends in serum albumin may have occurred either as a direct consequence of clinical increased mortality. A spontaneous increase in serum albumin may reflect a spectrum of events, including events or independently of them. It is not known whether intervention intended to promote an increase improved nutrition, stricter control of fluid balance,
